Examining Cardlytics, Inc.’s Alleged Securities Fraud and Investor Opportunity
The Schall Law Firm, renowned for its litigation stance on shareholder rights, is currently delving into claims concerning Cardlytics, Inc. (“Cardlytics” or “the Company”) bearing the ticker symbol CDLX on the NASDAQ, regarding possible violations of securities laws. Market’s Discontent Allegations revolve around potential misinformation disseminated by Cardlytics. Initially boasting their technology ventures as a ...










